Avalo Therapeutics (AVTX) Amortizatization of Intangibles (2017 - 2026)

Avalo Therapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $106000.0 for Q1 2026.

• Quarterly Amortizatization of Intangibles changed N/A year-over-year to $106000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $796000.0 (changed N/A YoY) and the FY2025 annual result came in at $690000.0, changed N/A from the prior year.
• Amortizatization of Intangibles was $106000.0 for Q1 2026 at Avalo Therapeutics, down from $197000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $900000.0 in Q3 2023 and bottomed at $106000.0 in Q1 2026.
• A 4-year average of $344000.0 and a median of $349000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
• Peak annual rise in Amortizatization of Intangibles reached 223.08% in 2022, while the deepest fall reached 0.0% in 2022.
• Avalo Therapeutics' Amortizatization of Intangibles stood at $349000.0 in 2022, then surged by 157.88% to $900000.0 in 2023, then sank by 78.11% to $197000.0 in 2025, then plunged by 46.19% to $106000.0 in 2026.
• Business Quant data shows AVTX's Amortizatization of Intangibles at $106000.0 in Q1 2026, $197000.0 in Q4 2025, and $347000.0 in Q3 2025.